52nd Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)

52nd Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) is organized by VEITHsymposium (Vs), Cleveland Clinic and will be held from Nov 18 - 22, 2025 at New York Hilton Midtown, New York City, New York, United States of America.

Description:
Vascular disease in all of its manifestations is a leading cause of death and disability affecting a large percentage of Americans over the age of 50. There is a critical need for physicians who diagnose, treat and manage patients with vascular disease to receive continuing medical education in this area. The latest pharmacologic, radiologic, surgical and endovascular techniques and technologies will be presented, along with discussions of when these treatments are justified and indicated and when they are not. Updates on clinical trials and opportunities for dialogue with experts in the field provide insight along with the latest data on the results of the various treatment modalities.

There is an enormous gap between actual practice and the current state of knowledge. This gap is filled imperfectly with material in books and published articles. These sources are also often negatively influenced by the biases of authors, reviewers and editors. VEITHsymposium attempts to fill this gap more perfectly and more currently by enlisting speakers with up-to-date information and data, and also those on both sides of controversial issues. In this way, the audience gets a current view of the state-of-the-art in vascular disease management as of the date of the meeting. All important topics are covered.

In addition, by having numerous short (5-6 minutes) talks followed by panel discussions and capturing the entire meeting on the web based library, the meeting will provide an electronic reference source to help vascular specialists in their practice decisions throughout the year. It will also provide the most up-to-date unbiased information possible to help with these decisions.

Focus:
The VEITHsymposium provides Vascular Surgeons and other Vascular Specialists with a five-day conference on the most current information about new developments in clinical practice and relevant research. Beginning Tuesday, the symposium offers over 1,300 fast-paced presentations on what is new and important in the treatment of vascular disease. Important updates and reevaluations, as well as the latest significant advances, changing concepts in diagnosis and management, pressing controversies and new techniques, agents and diagnostic modalities will be presented. Video case presentations will also be included.

Objectives:
Upon completion of the VEITHsymposium, the participants will, after learning about a wide array of topics, be able to:

• Explain the practical implications of clinical trial data on new technologies and techniques for endovascular repair of abdominal aortic aneurysm and thoracic aortic disease
• Summarize the impact of data on therapeutic advances for stroke and carotid disease management
• Compare the safety, efficacy, and therapeutic indications of pharmacologic agents to the management of vascular disease
• Assess data on the latest state-of-the-art for the treatment of superficial femoral and tibial artery disease and describe potential implications for clinical care
• Summarize recent data on treatment advances for venous disease and explain their clinical implications
• Provide new information about the latest developments in hemodialysis access and vascular malformations and tumors
• Incorporate the Vascular Laboratory into the management of patients with vascular disease
• Identify and compare noninvasive tests that are available to aid in the diagnosis of vascular disease